Hegde U - Search Results

1

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.

Ray S, Chhabra A, Chakraborty NG, Hegde U, Dorsky DI, Chodon T, von Euw E, Comin-Anduix B, Koya RC, Ribas A, Economou JS, Rosenberg SA, Mukherji B; UCLA-CALTECH-CHLA-USC-UCONN Consortium on Translational Program in Engineered Immunity. Ray S, et al. Among authors: hegde u. Clin Immunol. 2010 Sep;136(3):338-47. doi: 10.1016/j.clim.2010.04.013. Epub 2010 May 23. Clin Immunol. 2010. PMID: 20547105 Free PMC article.

2

Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly.

Chakraborty NG, Yadav M, Dadras SS, Singh P, Chhabra A, Feinn R, Kerr PE, Grant-Kels JM, Mukherji B, Hegde UP. Chakraborty NG, et al. Hum Immunol. 2013 May;74(5):640-7. doi: 10.1016/j.humimm.2013.01.015. Epub 2013 Feb 4. Hum Immunol. 2013. PMID: 23391568

3

Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies.

Hegde UP, Mukherji B. Hegde UP, et al. Cancer Immunol Immunother. 2017 Sep;66(9):1113-1121. doi: 10.1007/s00262-017-2007-x. Epub 2017 May 11. Cancer Immunol Immunother. 2017. PMID: 28497159 Free PMC article. Review.

4

Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro.

Chattopadhyay S, Mehrotra S, Chhabra A, Hegde U, Mukherji B, Chakraborty NG. Chattopadhyay S, et al. Among authors: hegde u. J Immunol. 2006 Jan 15;176(2):984-90. doi: 10.4049/jimmunol.176.2.984. J Immunol. 2006. PMID: 16393984

5

Metastatic melanoma in the older patient: immunologic insights and treatment outcomes.

Hegde UP, Chakraborty N, Mukherji B, Grant Kels JM. Hegde UP, et al. Expert Rev Pharmacoecon Outcomes Res. 2011 Apr;11(2):185-93. doi: 10.1586/erp.11.14. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21476820 Review.

6

Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death.

Mehrotra S, Chhabra A, Hegde U, Chakraborty NG, Mukherji B. Mehrotra S, et al. Among authors: hegde u. J Leukoc Biol. 2007 Feb;81(2):539-47. doi: 10.1189/jlb.0706479. Epub 2006 Oct 24. J Leukoc Biol. 2007. PMID: 17062604

7

Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.

Hegde U, Chhabra A, Chattopadhyay S, Das R, Ray S, Chakraborty NG. Hegde U, et al. Pathobiology. 2008;75(3):200-8. doi: 10.1159/000124981. Pathobiology. 2008. PMID: 18550918 Free article.

8

Melanoma in the elderly patient: relevance of the aging immune system.

Hegde UP, Chakraborty N, Kerr P, Grant-Kels JM. Hegde UP, et al. Clin Dermatol. 2009 Nov-Dec;27(6):537-44. doi: 10.1016/j.clindermatol.2008.09.012. Clin Dermatol. 2009. PMID: 19880041 Review.

9

Emerging immune therapy of metastatic melanoma in the older patient: does age really matter?

Hegde UP, Mukherji B, Grant-Kels JM. Hegde UP, et al. Melanoma Manag. 2016 Mar;3(1):9-12. doi: 10.2217/mmt.15.39. Epub 2016 Feb 17. Melanoma Manag. 2016. PMID: 30190868 Free PMC article. No abstract available.

10

Metastatic melanoma in the older patient: special considerations.

Hegde UP, Grant-Kels JM. Hegde UP, et al. Clin Dermatol. 2013 May-Jun;31(3):311-6. doi: 10.1016/j.clindermatol.2012.08.011. Clin Dermatol. 2013. PMID: 23608450 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters